Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 12;16:5451–5464. doi: 10.2147/IJN.S323671

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Liu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

LncRNA CHL1-AS1 in EMs-pMφ-exo promotes EMs lesions growth by increasing MDM2 in vivo. (A) Total volume of EMs lesions. (B) Total weight of EMs lesions. (C) qRT-PCR was carried out to measure the RNA expression of CHL1-AS1, miR-610, and MDM2 in EMs lesions. (D) MDM2 protein level in EMs lesions was detected by Western blot. **P < 0.01 versus the PBS, Con-pMφ-exo, and EMs-pMφ-exo^si-CHL1-AS1 groups.